The American Health Council Names Paul Aoun, DO/PhD, to Board of Physicians
July 19, 2017 08:00 ET
|
American Health Council
NEW YORK, July 19, 2017 (GLOBE NEWSWIRE) -- With eight years in Endocrine and Diabetes Care and five years in his current role as Clinical Endocrinologist at Palm Beach Diabetes and Endocrine...
Wonder Dressing Saved my Foot
July 17, 2017 11:19 ET
|
Crawford Healthcare
DOYLESTOWN, Pa. and CHESHIRE, U.K., July 17, 2017 (GLOBE NEWSWIRE) -- A 47-year-old Indianapolis, Indiana woman has had her foot saved from amputation just hours before undergoing surgery, thanks to...
PreveCeutical signs Research and Option Agreement with UniQuest Pty Limited for Developing Dual-Gene Therapy Treatment for Diabetes and Obesity
July 17, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces, further to its news release dated April 13, 2017,...
CrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discovery
July 06, 2017 08:00 ET
|
Crown Bioscience
SANTA CLARA, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...
Solera Health Further Bolsters Executive Management Team with Appointment of Brian Esterly as Chief Operating Officer
June 28, 2017 10:00 ET
|
Solera Health
PHOENIX, June 28, 2017 (GLOBE NEWSWIRE) -- Solera Health, a preventive services benefits manager, announced today that it has further strengthened its executive management team with the strategic...
WellDoc® Provides BlueStar® to New Class in American Diabetes Association of Maryland’s “The Fabulous YOU!” Program
June 27, 2017 09:00 ET
|
WellDoc Inc.
COLUMBIA, Md., June 27, 2017 (GLOBE NEWSWIRE) -- WellDoc®, the leading digital health technology company revolutionizing chronic disease management, announced today its support of the American...
Xeris Pharmaceuticals Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program
June 16, 2017 07:51 ET
|
Xeris Pharmaceuticals, Inc.
CHICAGO, IL and AUSTIN, TX, June 16, 2017 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”) announced today that results from three clinical studies of the company’s investigational...
ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
June 12, 2017 09:00 ET
|
ProLynx LLC
SAN FRANCISCO, June 12, 2017 (GLOBE NEWSWIRE) -- In a late-breaking abstract at the 77th American Diabetes Association meeting in San Diego, ProLynx LLC announced a novel drug delivery system to...
Orgenesis to Present at the 2017 Marcum MicroCap Conference
June 12, 2017 08:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Jun 12, 2017) - Orgenesis Inc. (OTCQB: ORGS), a vertically-integrated biopharmaceutical company with expertise and unique experience in cell therapy development and...
Origin™ Announces First 50 Patients Randomized, and Full Site Activation in Phase IIb Dose-Ranging Study for Diabetic Foot Ulcers
June 01, 2017 08:30 ET
|
Origin
PRINCETON, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Origin, Inc. (formerly Advanced Plasma Therapies, Inc), a Princeton, NJ based clinical-stage wound care company focused on treatment of Diabetic...